BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1984822)

  • 1. Etoposide. Current and future status.
    Aisner J; Lee EJ
    Cancer; 1991 Jan; 67(1 Suppl):215-9. PubMed ID: 1984822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.
    Sinkule JA
    Pharmacotherapy; 1984; 4(2):61-73. PubMed ID: 6326063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide: current status and future perspectives in the management of malignant neoplasms.
    Belani CP; Doyle LA; Aisner J
    Cancer Chemother Pharmacol; 1994; 34 Suppl():S118-26. PubMed ID: 8070020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic etoposide administration: overview of clinical experience.
    Greco FA
    Cancer Treat Rev; 1993; 19 Suppl C():35-45. PubMed ID: 8221715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose etoposide and marrow transplantation.
    Herzig RH
    Cancer; 1991 Jan; 67(1 Suppl):292-8. PubMed ID: 1984830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions for etoposide therapy.
    Greco FA
    Cancer; 1991 Jan; 67(1 Suppl):315-8. PubMed ID: 1984834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I study of etoposide phosphate plus paclitaxel.
    Brooks DJ; Alberts DS
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):30-3. PubMed ID: 8996573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic oral etoposide: trials at Indiana University and with the Hoosier Oncology Group.
    Loehrer PJ
    Semin Oncol; 1992 Dec; 19(6 Suppl 14):48-52. PubMed ID: 1336900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose etoposide (VP-16) in small-cell lung cancer.
    Greco FA; Johnson DH; Hande KR; Porter LL; Hainsworth JD; Wolff SN
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):42-4. PubMed ID: 2983434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of standard-dose etoposide in the management of non-small cell lung cancer.
    Ruckdeschel JC
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):39-44. PubMed ID: 1337219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of etoposide in the management of small cell lung cancer.
    Johnson DH; Hainsworth JD; Hande KR; Greco FA
    Cancer; 1991 Jan; 67(1 Suppl):231-44. PubMed ID: 1845846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etoposide therapy for testicular cancer.
    Loehrer PJ
    Cancer; 1991 Jan; 67(1 Suppl):220-4. PubMed ID: 1984823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide: seeking the best dose and schedule.
    Greco FA
    Semin Oncol; 1992 Dec; 19(6 Suppl 14):59-63. PubMed ID: 1488656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.
    Slevin ML; Clark PI; Joel SP; Malik S; Osborne RJ; Gregory WM; Lowe DG; Reznek RH; Wrigley PF
    J Clin Oncol; 1989 Sep; 7(9):1333-40. PubMed ID: 2549204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
    Hammond LA; Eckardt JR; Ganapathi R; Burris HA; Rodriguez GA; Eckhardt SG; Rothenberg ML; Weiss GR; Kuhn JG; Hodges S; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1998 Jun; 4(6):1459-67. PubMed ID: 9626463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide in the treatment of leukemias.
    Bishop JF
    Semin Oncol; 1992 Dec; 19(6 Suppl 13):33-8. PubMed ID: 1492226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K; Doroshow JH; Ahn C; Hamasaki V; Leong L; Morgan R; Raschko J; Shibata S; Somlo G; Tetef M
    J Clin Oncol; 1996 Oct; 14(10):2631-7. PubMed ID: 8874321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
    Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
    Cairo MS
    Semin Oncol; 1995 Jun; 22(3 Suppl 7):23-7. PubMed ID: 7610395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.